Annette Feussner

820 total citations
15 papers, 626 citations indexed

About

Annette Feussner is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Annette Feussner has authored 15 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 5 papers in Genetics and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Annette Feussner's work include Hemophilia Treatment and Research (8 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers). Annette Feussner is often cited by papers focused on Hemophilia Treatment and Research (8 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers). Annette Feussner collaborates with scholars based in Germany, United States and Switzerland. Annette Feussner's co-authors include Jürgen Römisch, Jen‐Fue Maa, Karen Brown, Hamim Zahir, Ling He, Hans Lanz, Elliott M. Antman, Alexander G. Vandell, Madhuri Desai and Michael Grosso and has published in prestigious journals such as Circulation, Journal of Allergy and Clinical Immunology and European Journal of Biochemistry.

In The Last Decade

Annette Feussner

15 papers receiving 610 citations

Peers

Annette Feussner

HEMAT

CCM

GENET

Nina Lasky United States

Geerte L. Van Sluis Netherlands

R. Consonni Italy

Sandra Régina France

L. Engesser Netherlands

Malcolm A. Cunningham Australia

M.C. Trzeciak France

Virtudes Vila Spain

Eunyoung Lee South Korea

Mark Schneider Canada

Nina Lasky United States

Annette Feussner

662 ×2.0

HEMAT

108 ×0.5

CCM

94 ×0.6

274 ×1.9

GENET

155 ×2.5

Citations per year, relative to Annette Feussner Annette Feussner (= 1×) peers Nina Lasky

Countries citing papers authored by Annette Feussner

Since Specialization

Citations

This map shows the geographic impact of Annette Feussner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Feussner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Feussner more than expected).

Fields of papers citing papers by Annette Feussner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Feussner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Feussner. The network helps show where Annette Feussner may publish in the future.

Co-authorship network of co-authors of Annette Feussner

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Feussner. A scholar is included among the top collaborators of Annette Feussner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Feussner. Annette Feussner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Feussner, Annette, et al.. (2022). Fit-for-purpose validation of a drug-tolerant immunogenicity assay for a human mAb drug in animal safety studies. Journal of Immunological Methods. 512. 113406–113406. 2 indexed citations

Schnell, Anna, Fernando Moreira, Irina Irincheeva, et al.. (2021). Airway inflammation and dysbiosis in antibody deficiency despite the presence of IgG. Journal of Allergy and Clinical Immunology. 149(6). 2105–2115.e10. 8 indexed citations

Holme, Pål André, et al.. (2019). Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency. Hematology. 25(1). 17–25. 5 indexed citations

Pawaskar, Dipti, Michael A. Tortorici, Bruce L. Zuraw, et al.. (2018). Population pharmacokinetics of subcutaneous C1‐inhibitor for prevention of attacks in patients with hereditary angioedema. Clinical & Experimental Allergy. 48(10). 1325–1332. 8 indexed citations

Roberts, John, et al.. (2017). Population pharmacokinetics of recombinant coagulation factor VIII‐SingleChain in patients with severe hemophilia A. Journal of Thrombosis and Haemostasis. 15(6). 1106–1114. 33 indexed citations

Ledger, Katie St., Annette Feussner, Uwe Kalina, et al.. (2017). International comparative field study evaluating the assay performance of AFSTYLA in plasma samples at clinical hemostasis laboratories. Journal of Thrombosis and Haemostasis. 16(3). 555–564. 29 indexed citations

Klamroth, Robert, Mindy Simpson, Joan Cox Gill, et al.. (2016). Comparative pharmacokinetics of rVIII‐SingleChain and octocog alfa (Advate^®) in patients with severe haemophilia A. Haemophilia. 22(5). 730–738. 42 indexed citations

Feussner, Annette, et al.. (2014). Biochemical comparison of four commercially available C1 esterase inhibitor concentrates for treatment of hereditary angioedema. Transfusion. 54(10). 2566–2573. 22 indexed citations

Zahir, Hamim, Karen Brown, Alexander G. Vandell, et al.. (2014). Edoxaban Effects on Bleeding Following Punch Biopsy and Reversal by a 4-Factor Prothrombin Complex Concentrate. Circulation. 131(1). 82–90. 201 indexed citations

10.

Martinez‐Saguer, Inmaculada, Marco Cicardi, Chiara Suffritti, et al.. (2013). Pharmacokinetics of plasma‐derived C1‐esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study. Transfusion. 54(6). 1552–1561. 31 indexed citations

11.

Roemisch, Juergen, et al.. (2002). The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP). Blood Coagulation & Fibrinolysis. 13(5). 433–441. 53 indexed citations

12.

Kannemeier, Christian, et al.. (2001). Factor VII and single‐chain plasminogen activator‐activating protease. European Journal of Biochemistry. 268(13). 3789–3796. 55 indexed citations

13.

Römisch, Jürgen, et al.. (2001). Quantitation of the factor VII- and single-chain plasminogen activator-activating protease in plasmas of healthy subjects. Blood Coagulation & Fibrinolysis. 12(5). 375–383. 36 indexed citations

14.

Römisch, Jürgen, et al.. (1999). The FVII Activating Protease Cleaves Single-Chain Plasminogen Activators. Pathophysiology of Haemostasis and Thrombosis. 29(5). 292–299. 92 indexed citations

15.

Weiss, Norbert, et al.. (1999). Influence of folic acid, pyridoxal phosphate and cobalamin on plasma homocyst(e)ine levels and the susceptibility of low-density lipoprotein to ex-vivo oxidation.. PubMed. 4(10). 425–32. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact